Uncategorized

State R&D Tax Credit by State: Which States Stack on Top of the Federal Section 41 Credit

By The Ledgerism Editorial Team · The Ledgerism Brief Editorial Team produces original, methodology-disclosed accounting and tax research—data trackers, databases, and reference guides built to be the most-cited source in the field. Every figure is verified against primary sources including FASB, the IRS, the PCAOB, NASBA, the AICPA, and state boards of accountancy.

A state R&D tax credit is a research incentive that more than 35 states stack on top of the federal Section 41 credit, often letting a company claim a state credit for the same qualified research expenses it already used federally. The state credits vary enormously in rate, refundability, and how closely they follow the federal definition of qualified research. For a company doing meaningful research, the combined federal and state benefit can recover well over 15 percent of qualified spending.

What is a state R&D tax credit?

A state research and development tax credit is a state-level incentive that reduces a company’s state tax liability based on its qualified research spending. It mirrors, in structure, the federal research credit under Section 41 of the Internal Revenue Code, but it is a separate benefit granted by the state and claimed on the state return. Because the two operate in parallel, a company that conducts qualified research can often claim both the federal credit and one or more state credits on the same underlying expenses, multiplying the recovery.

The federal credit is the anchor. Section 41 provides a credit, generally computed as a percentage of qualified research expenses above a base amount, for research that satisfies the four-part test in IRC §41(d): the research must be intended to develop or improve a business component, be technological in nature, aim to eliminate uncertainty, and involve a process of experimentation. Qualified research expenses under IRC §41(b) include in-house wages for qualified services, supplies used in research, and a portion of contract research costs. Most states adopt this federal framework by reference, so a company that has documented its federal credit has done most of the work for the state credit too.

What states change is the rate, the cap, the refundability, and sometimes the base-amount mechanics. A state might offer a credit at 5 percent or at 15 percent. It might cap the total annual credits the state will grant. It might refund unused credits in cash, allow them to be carried forward, or even let them be sold or transferred to another taxpayer. Those design choices are where the real differences between states live, and they determine whether a state credit is worth pursuing for a given company.

Who is affected and who benefits

State R&D credits benefit any company that performs qualified research within a state that offers a credit. The classic candidates are:

• Technology and software companies developing new or improved products and processes.
• Manufacturers improving production techniques, tooling, or product designs.
• Life-sciences, biotech, and pharmaceutical firms conducting clinical and laboratory research.
• Engineering and architecture firms developing novel technical solutions.
• Startups, which in many states can use the credit even before they are profitable if the state credit is refundable or can offset payroll or franchise taxes.

The benefit accrues to the entity that incurs the qualified research expenses, though for pass-through entities the credit generally flows to the owners to use against their own state liability. A profitable company uses the credit to reduce tax due. A pre-profit startup benefits only where the state credit is refundable or can be applied against a non-income tax, such as Texas’s franchise tax credit or a payroll-style offset.

The threshold question is always whether the research qualifies. A company claiming a state credit should already have a defensible federal credit, because the documentation, the four-part test, and the expense categories carry over. Our coverage of the R&D tax credit walks through the federal mechanics, and the federal claim is reported on Form 6765 R&D credit instructions. Because the credit and the new capitalization rules interact, companies should also understand Section 174 R&D capitalization, which changed how research costs are deducted even though it did not change the §41 credit.

How state R&D credits work (mechanics)

State credits generally follow a four-step logic, with the variation concentrated in steps three and four.

Step one, identify qualified research expenses. Most states adopt the federal definition under IRC §41(b), so the company uses the same wages, supplies, and contract research it identified for the federal credit, limited to research activities performed within the state. A few states modify the definition or require the research to occur at an in-state facility.

Step two, compute the base and the credit. Like the federal credit, many states compute the credit on qualified expenses above a base amount tied to a historical ratio of research to gross receipts, or use a simplified alternative method. The state then applies its credit rate to the excess.

Step three, apply the state’s rate and caps. This is where states diverge. Rates range from the low single digits to 15 percent or more, and many states cap either the per-taxpayer credit or the aggregate credits the state will award in a year. Some states require pre-approval or allocation from a limited annual pool, meaning the credit is not guaranteed even to a qualifying company.

Step four, use, carry forward, refund, or transfer the credit. A nonrefundable credit can only offset state tax due, with the excess carried forward for a set number of years. A refundable credit pays the unused portion in cash, which is decisive for pre-profit startups. A transferable credit can be sold to another taxpayer, turning the credit into near-cash even for a company with no tax liability. Pennsylvania’s credit, for example, is transferable, which has created an active market in the credits.

State R&D credit comparison

The table below summarizes representative features of several widely used state R&D credit programs as of early 2026. Rates, caps, and refundability change through state legislation, so the current statute and department-of-revenue guidance for each state govern.

Three design themes emerge. First, refundability is rare and valuable. Arizona’s partial refund (up to $5 million with approval) and New York’s refundable Excelsior component stand out because they put cash in the hands of pre-profit companies, whereas California, Massachusetts, and Pennsylvania only let the credit offset tax. Second, some states substitute transferability for refundability: Pennsylvania lets a company that cannot use its credit sell it, and Connecticut allows certain taxpayers to exchange unused credits with the state at a discount. Third, several of the richest programs are discretionary and capped, meaning a qualifying company must apply and may not receive an allocation if the annual pool is exhausted.

Worked example

Assume Meridian Systems, a software company, incurs $2,000,000 of qualified research expenses, of which $1,500,000 relate to research performed in California and $500,000 to research performed in Pennsylvania. Assume for simplicity that the full amounts exceed the applicable base amounts, so the credit rate applies to the full figures, and that the company is profitable enough to use nonrefundable credits in California.

Federal credit. Meridian first claims the federal credit under IRC §41 on the full $2,000,000 of qualified research expenses, reported on Form 6765. The federal credit reduces federal tax (or, for an eligible small business, can offset payroll tax). This federal benefit is independent of the state credits.

California credit. California’s general R&D credit rate is 15 percent. Applied to the $1,500,000 of California qualified research expenses (above base, as assumed), the California credit is approximately $225,000. Because California’s credit is nonrefundable, Meridian uses it to offset its California franchise or income tax and carries forward any excess. The same $1,500,000 of expenses generated both a federal credit and this state credit.

Pennsylvania credit. Pennsylvania’s credit for a large business is roughly 10 percent of the increase in research expenses. Applied to the $500,000 of Pennsylvania qualified research expenses (above base, as assumed), the credit is approximately $50,000, subject to the state’s annual cap and allocation. If Meridian cannot use the full Pennsylvania credit against its tax, it may sell the credit to another taxpayer, because the Pennsylvania credit is transferable.

Combined picture. On $2,000,000 of total qualified research expenses, Meridian captures a federal credit plus roughly $225,000 in California and $50,000 in Pennsylvania, layering state benefits on top of the federal one. The state credits track the location of the research: California expenses generate the California credit and Pennsylvania expenses the Pennsylvania credit, which is why a company with multistate research must allocate its qualified expenses by state.

Recent changes (2025 to 2026 law changes)

The most important federal development affecting research incentives is the treatment of research expenditures under IRC §174. The Tax Cuts and Jobs Act had required taxpayers, beginning in 2022, to capitalize and amortize research and experimental expenditures (over five years for domestic research, fifteen for foreign) rather than deducting them immediately. The One Big Beautiful Bill Act, signed July 4, 2025 (Pub. L. 119-21), restored immediate expensing for domestic research expenditures and provided relief for amounts capitalized in the interim years. Crucially, the §174 capitalization rules govern the deduction, not the §41 credit. The research credit itself was unchanged, and most state R&D credits continue to reference the §41 framework regardless of how §174 treats the deduction.

At the state level, the changes are program-specific. States periodically adjust their credit rates, annual caps, refundability, and approval processes through legislation and budget acts. California, in particular, has at times imposed temporary limits on the total business credits a taxpayer may use in a year during budget shortfalls, which can defer (though not eliminate) the use of an otherwise valid R&D credit because the credit carries forward. Practitioners should confirm each state’s current rate, cap, and any usage limitation against that state’s statute and revenue-department guidance for the filing year, because these features change frequently and a stale rate can misstate the benefit.

The structural trend worth watching is the slow spread of refundability and transferability. Because pre-profit startups cannot use a nonrefundable income-tax credit, states competing for research activity have increasingly added refundable components, payroll-tax offsets, or transferable credits to make the incentive useful to early-stage companies. Arizona’s partial refund and Pennsylvania’s transferable credit are leading examples of this design.

Common pitfalls

• Assuming every state conforms to the federal definition. Most states adopt IRC §41(b) and §41(d), but a few modify the definition of qualified research or require the work to occur at an in-state facility. Applying the federal definition blindly can overstate the state credit.
• Failing to allocate qualified expenses by state. A state credit generally applies only to research performed in that state. A company with multistate research must source its wages, supplies, and contract research to each state rather than claiming the full federal figure in every state.
• Ignoring annual caps and allocation processes. Several states (Pennsylvania and Arizona’s refundable portion among them) limit the credits awarded each year and require application or approval. A qualifying company that does not apply, or applies after the pool is exhausted, may receive nothing.
• Expecting a refund from a nonrefundable credit. California, Massachusetts, and Pennsylvania credits are nonrefundable; they offset tax and carry forward. A pre-profit company that expects cash from a nonrefundable credit will be disappointed and should look for refundable or transferable programs instead.
• Confusing the §174 capitalization change with the §41 credit. The §174 rules govern the deduction of research costs, not the credit. The credit under §41 (and the state credits that reference it) survived the §174 changes intact.
• Weak documentation of the four-part test. A state will deny a credit for activities that fail the IRC §41(d) four-part test just as the IRS would. Inadequate project documentation, time tracking, or technical-uncertainty evidence undermines both the federal and the state claim.
• Missing the basic-research and specialty components. Several states offer enhanced rates for payments to qualified universities or for basic research (California’s 24 percent, Massachusetts’s 15 percent component). Claiming only the general rate leaves money unclaimed.

Frequently asked questions

Can I claim a state R&D credit and the federal credit on the same expenses?

Generally yes. The federal credit under IRC §41 and a state R&D credit operate in parallel, and most states let a company claim the state credit on the same qualified research expenses used federally, limited to research performed within the state.

How many states offer an R&D credit?

More than 35 states offer some form of research and development tax credit. The rates, caps, refundability, and conformity to the federal definition vary considerably from state to state.

Which states refund unused R&D credits in cash?

Only some. Arizona refunds a portion (up to $5 million with approval), and New York’s Excelsior R&D component is refundable, among others. Many states, including California, Massachusetts, and Pennsylvania, are nonrefundable, though Pennsylvania’s credit can be sold and Connecticut allows certain credits to be exchanged with the state.

Do state credits use the federal definition of qualified research?

Most do. The majority of states incorporate the IRC §41(b) expense definition and the §41(d) four-part test by reference. A minority modify the definition or impose in-state facility requirements, so the specific state statute should be checked.

Did the Section 174 capitalization change affect the credit?

No. Section 174 governs how research costs are deducted, and the One Big Beautiful Bill Act restored immediate domestic expensing in 2025. The Section 41 credit, and the state credits that reference it, were not changed by the §174 rules.

Can a pre-profit startup benefit from a state R&D credit?

It depends on the state. A startup benefits where the credit is refundable (Arizona, New York Excelsior), transferable (Pennsylvania), or can offset a non-income tax such as Texas’s franchise tax. A nonrefundable income-tax credit is only useful once the company has state tax to offset, though it can carry forward.

What is the most generous state R&D credit?

It depends on the metric. California offers a high 15 percent general rate (24 percent for basic research) but is nonrefundable. Arizona is notable for refundability up to $5 million. Pennsylvania’s transferability makes its credit close to cash even for non-taxpayers. The best program for a given company turns on profitability and where the research is performed.

How do I allocate research expenses across states?

State credits generally apply only to research performed in that state, so a company sources its qualified wages, supplies, and contract research to each state based on where the work was done, rather than claiming the full federal figure in every state.